A Resource for Healthcare and Social Services Professionals
June 11, 2021
12:00 pm–1:00 pm ET
This one-hour training prepares nurses and other medical professionals to use long-acting injectable buprenorphine (Sublocade) in addiction treatment.
This is a one-hour training that prepares nurses offering medication for opioid-use disorder to manage addiction treatment with long-acting injectable buprenorphine. Topics covered will include: the pharmacology of long-acting injectable buprenorphine; patient selection; medication storage and administration; clinical logistics; side effects; supplemental dosing; lessons learned from the field; and billing and specialty pharmacies. We will also have an open discussion to learn from each other’s experiences with using this treatment.
This training will be held via Zoom. We would prefer that you log in using a computer with a web cam so that we can all connect to each other via video. Please note that signing on with video is required to receive CEs. If you do not have access to a web cam, please let us know.
The Zoom link for this training is password protected. The password will be emailed to you ahead of the training.
Attendance is required for all OBAT nurses and MAs who work in a DPH/BSAS funded STATE OBOT program. All others working with patients on injectable buprenorphine are welcome and encouraged to attend.
By the end of the training, participants will be able to:
Boston Medical Center Grayken Center for Addiction, Department of Public Health, Bureau of Addiction Services
Boston Medical Center grants 1.00 hours to all nurses who attend and complete the evaluation. Boston Medical Center is approved as a provider of continuing professional development by American Nurses Association, Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.